SCHEMBL4207693

SCHEMBL4207693

Cn1nccc1-c1cc(NC(=O)COc2ccccc2Cl)ccc1OCCN1CCCCC1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.75
HTR2C P28335 17/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3948502 0.93 HTR2A (0.71) HTR2AHTR2C
SCHEMBL3947420 0.91 HTR2A (0.72) HTR2AHTR2C
SCHEMBL4037998 0.91 HTR2A (0.73) HTR2AHTR2C
SCHEMBL4042172 0.90 HTR2A (0.75) HTR2AHTR2C
SCHEMBL4041233 0.90 HTR2A (0.71) HTR2AHTR2C
SCHEMBL4037413 0.89 HTR2A (0.74) HTR2AHTR2C
SCHEMBL3944658 0.89 HTR2A (0.78) HTR2AHTR2C
SCHEMBL14385273 0.88 HTR2A (0.76) HTR2AHTR2C
SCHEMBL4218048 0.88 HTR2A (0.80) HTR2AHTR2C
SCHEMBL4354992 0.87 HTR2A (0.78) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed